TY - JOUR
T1 - Prolonged secretion of IL-15 in patients with severe forms of acute graft-versus-host disease after allogeneic bone marrow transplantation in children
AU - Kumaki, Satoru
AU - Minegishi, Masayoshi
AU - Fujie, Hiromi
AU - Sasahara, Yoji
AU - Ohashi, Yoshiyuki
AU - Tsuchiya, Shigeru
AU - Konno, Tasuke
PY - 1998/4
Y1 - 1998/4
N2 - Graft-versus-host disease (GVHD) is one of the most common and fatal complications that follows allogeneic bone marrow transplantation (BMT). Donor origin T cells are responsible for the initiation of GVHD. In this report, we demonstrate that conditioning regimens for BMT resulted in elevated serum levels of interleukin-15 (IL-15), which reached maximum levels within 15 days and returned to basal levels within 25 days after allogeneic BMT, in all patients examined. Thereafter, circulating IL-15 was detected only in patients with grade III or IV acute GVHD with gut involvement. In contrast, IL-2 was not detected at any time in these patients. Since IL-15 is able to activate antigen-stimulated T cells and natural killer (NK) cells, IL-15 may play an important role in the development of severe forms of acute GVHD.
AB - Graft-versus-host disease (GVHD) is one of the most common and fatal complications that follows allogeneic bone marrow transplantation (BMT). Donor origin T cells are responsible for the initiation of GVHD. In this report, we demonstrate that conditioning regimens for BMT resulted in elevated serum levels of interleukin-15 (IL-15), which reached maximum levels within 15 days and returned to basal levels within 25 days after allogeneic BMT, in all patients examined. Thereafter, circulating IL-15 was detected only in patients with grade III or IV acute GVHD with gut involvement. In contrast, IL-2 was not detected at any time in these patients. Since IL-15 is able to activate antigen-stimulated T cells and natural killer (NK) cells, IL-15 may play an important role in the development of severe forms of acute GVHD.
KW - Acute GVHD
KW - BMT
KW - Interleukin-15
UR - http://www.scopus.com/inward/record.url?scp=0032053098&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032053098&partnerID=8YFLogxK
U2 - 10.1016/s0925-5710(97)00117-5
DO - 10.1016/s0925-5710(97)00117-5
M3 - Article
C2 - 9650452
AN - SCOPUS:0032053098
SN - 0925-5710
VL - 67
SP - 307
EP - 312
JO - International Journal of Hematology
JF - International Journal of Hematology
IS - 3
ER -